Topoisomerase II as a Novel Antiviral Target against Panarenaviral Diseases

Persistent ID (NDL): info:ndljp/pid/12864111

Material type: 博士論文

Author: Afowowe, Tosin Oladipo

Publisher: MDPI

Publication date: 2023-03-20

Material Format: Digital

Capacity, size, etc.: -

Name of awarding university/degree: Nagasaki University (長崎大学),博士(医学)

View All

Notes on use at the National Diet Library

本資料は、掲載誌(URI)等のリンク先にある学位授与機関のWebサイトやCiNii Dissertationsから、本文を自由に閲覧できる場合があります。

Notes on use

Note (General)：: Although many arenaviruses cause severe diseases with high fatality rates each year, treatment options are limited to off-label use of ribavirin, and ...

Search by Bookstore

Read this material in an accessible format.

View materials in accessible formats for people with print disabilities (1Type)

Search by Bookstore

Read in Disability Resources

Other Services
- テキストデータ check it on 国立国会図書館デジタルコレクション

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type: 博士論文
Title: Topoisomerase II as a Novel Antiviral Target against Panarenaviral Diseases
Author/Editor: Afowowe, Tosin Oladipo
Author Heading: Afowowe, Tosin Oladipo
Publication, Distribution, etc.: MDPI
Publication Date: 2023-03-20
Publication Date (W3CDTF): 2023-03-20
Alternative Title: トポイソメラーゼIIは汎アレナウイルス病に対する新規抗ウイルス薬の標的となり得る
Degree grantor/type: Nagasaki University (長崎大学)
Date Granted: 2023-03-20
Date Granted (W3CDTF): 2023-03-20
Dissertation Number: 甲医歯薬第1523号
Degree Type: 博士(医学)
Text Language Code: eng
Subject Heading: arenaviruses
minigenome
drug screening
topoisomerase II
panarenaviral replication inhibitors
Target Audience: 一般
Note (General): Although many arenaviruses cause severe diseases with high fatality rates each year, treatment options are limited to off-label use of ribavirin, and a Food and Drug Administration (FDA)-approved vaccine is not available. To identify novel therapeutic candidates against arenaviral diseases, an RNA polymerase I-driven minigenome (MG) expression system for Lassa virus (LASV) was developed and optimized for high-throughput screening (HTS). Using this system, we screened 2595 FDA-approved compounds for inhibitors of LASV genome replication and identified multiple compounds including pixantrone maleate, a topoisomerase II inhibitor, as hits. Other tested topoisomerase II inhibitors also suppressed LASV MG activity. These topoisomerase II inhibitors also inhibited Junin virus (JUNV) MG activity and effectively limited infection by the JUNV Candid #1 strain, and siRNA knockdown of both topoisomerases (IIα and IIβ) restricted JUNV replication. These results suggest that topoisomerases II regulate arenavirus replication and can serve as molecular targets for panarenaviral replication inhibitors.
長崎大学学位論文学位記番号:博(医歯薬)甲第1523号学位授与年月日:令和5年3月20日
Author: Tosin Oladipo Afowowe, Yasuteru Sakurai, Shuzo Urata, Vahid Rajabali Zadeh, Jiro Yasuda
Citation: Viruses, 15(1), art. no. 105; 2022
identifier:Nagasaki University (長崎大学), 博士(医学) (2023-03-20)
http://hdl.handle.net/10069/00042264
Persistent ID (NDL): info:ndljp/pid/12864111
https://dl.ndl.go.jp/pid/12864111
Collection: 障害者向け資料
Collection (Materials For Handicapped People:1): テキストデータ
Collection (particular): 国立国会図書館デジタルコレクション > デジタル化資料 > 博士論文
https://dl.ndl.go.jp/collections/A00014
Acquisition Basis: 博士論文（自動収集）
Date Accepted (W3CDTF): 2023-05-05T22:12:35+09:00
Format (IMT): application/pdf
Access Restrictions: 国立国会図書館内限定公開
Service for the Digitized Contents Transmission Service: 図書館・個人送信対象外
Availability of remote photoduplication service: 可
Periodical Title (URI): http://hdl.handle.net/10069/00042356
Data Provider (Database): 国立国会図書館 : 国立国会図書館デジタルコレクション
https://dl.ndl.go.jp